Clin2
NCT06855680Possibly a fitRecruiting

EMIRATES: Observing low-risk thyroid cancer without completion surgery

Differentiated Thyroid Cancer (DTC)

Part of Cancer clinical trials.

This study tests whether it is safe to monitor small, low-risk thyroid cancers (1–4 cm) instead of removing the remaining thyroid tissue after initial surgery. It may help you avoid a second operation and lifelong medication if your cancer is truly low-risk.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have a low-risk, well-differentiated thyroid cancer (papillary or follicular type), 1–4 cm in size
  • Your cancer was confirmed by a needle biopsy (Thy5 grade) or after removal of one side of your thyroid
  • You are able to communicate in spoken and written English
  • You do not have high-risk features like aggressive cell types, spread beyond the thyroid, lymph node involvement, or metastases

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07536412Not yet recruiting
Decision aid for low-risk thyroid cancer

This study tests a decision aid to help people with low-risk thyroid cancer or suspicious nodules make informed choices about their care. It may help you understand your options and feel more confident in your decisions.

Baltimore, Maryland
NCT05604963Recruiting
Half or full thyroid surgery for low-risk thyroid cancer

This study looks at people with low-risk thyroid cancer who have already had (or are about to have) surgery, comparing half-thyroid removal versus full-thyroid removal. It may help doctors choose the safest and most effective surgery for your cancer type and risk level.

Crewe, Cheshire
NCT06261190Enrolling by invitation
Active monitoring for low-risk thyroid cancer

This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.

Goyang-si
NCT06971965Not yet recruiting
Thyroid hormone treatment in active surveillance for small thyroid cancer

This study tests whether taking thyroid hormone to lower TSH (a hormone that can stimulate thyroid cancer) is necessary for people with very small, low-risk thyroid cancers who choose active surveillance (monitoring instead of immediate surgery). It aims to find out if skipping this treatment is safe and helps avoid side effects.

NCT06653257Not yet recruiting
Monitoring low-risk thyroid nodules instead of surgery

This study watches low-risk thyroid nodules over time instead of removing them with surgery. It aims to see if careful monitoring is a safe option for people with certain thyroid nodules.

Medellín, Antioquia
NCT02609685Recruiting
Active monitoring for tiny papillary thyroid cancer

This study looks at whether closely watching (without immediate surgery or treatment) a very small thyroid cancer can be safe. You may benefit by avoiding unnecessary procedures, while the team monitors your thyroid and any changes over time.

Los Angeles, California

Hear when a new Differentiated Thyroid Cancer (DTC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.